RMgmDB - Rodent Malaria genetically modified Parasites

Summary

RMgm-5550
Malaria parasiteP. berghei
Genotype
DisruptedGene model (rodent): PBANKA_1110700; Gene model (P.falciparum): PF3D7_0511200; Gene product: Stearoyl-CoA desaturase (Scd)
Transgene
Transgene not Plasmodium: GFP
Promoter: Gene model: Not available; Gene model (P.falciparum): Not available; Gene product: Not available
3'UTR: Gene model: Not available; Gene product: Not available
Insertion locus: Gene model: PBANKA_1110700; Gene product: Stearoyl-CoA desaturase (Scd)
Phenotype Liver stage;
Last modified: 25 September 2024, 10:23
  *RMgm-5550
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene disruption, Introduction of a transgene
Reference (PubMed-PMID number) Reference 1 (PMID number) : 38419272
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherNarwal SK, Mishra A
Name Group/DepartmentDivision of Molecular Microbiology and Immunology
Name InstituteCSIR-Central Drug Research Institute
CityLucknow
CountryIndia
Name of the mutant parasite
RMgm numberRMgm-5550
Principal nameScd KO
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystNot different from wild type
SporozoiteNot different from wild type
Liver stageScd KO sporozoites infect the liver but fail to establish blood-stage infections in mice.
Scd KO sporozoites were allowed to invade HepG2 cells and sporozoites present inside and outside of the cells were counted, which revealed normal invasion by KO sporozoites. To analyze EEF development progress in vivo, infected mouse livers were harvested at 36, 55, and 72 hpi, and parasite burden was quantified by measuring 18S rRNA copy number using real-time PCR. We found that the 18S rRNA copy number was comparable in WT GFP and KO parasites at 36 hpi, but it was significantly lower at 55 hpi in KO parasites than in WT GFP parasites. However, the 18S rRNA copy number at 72 hpi was significantly lower in WT GFP than in KO, which suggested that mature WT GFP parasites egress from the liver but that KO parasites failed to mature and remained in the liver. We confirmed the maturation defect by determining the merozoite surface protein 1 (MSP1) transcripts at 55 hpi and found that it was significantly decreased in the KO parasites.

Scd KO liver stages grow normally but do not form hepatic merozoites.
HepG2 cells were infected with sporozoites, and the culture was fixed at different time points and stained with anti-UIS4 antibody and Hoechst. The Scd KO parasites grew similarly to the WT GFP parasites during liver-stage development. We counted the EEF numbers and measured the size at 36, 48, and 62 hpi and found comparable numbers and sizes in Scd KO and WT GFP parasites. Next, we checked the formation of merozoites by staining with an anti-MSP1 antibody. WT GFP showed nuclear segregation and merozoite formation. In contrast, there was abnormal DNA segregation in Scd KO parasites and merozoite formation was abolished. We counted the nuclei in the EEF, which were found to be significantly fewer in Scd KO parasites.
Additional remarks phenotype

Mutant/mutation
The mutant lacks expression of Scd and expresses GFP (under a constitutive promoter).

Protein (function)
The malaria parasite can modify fatty acids, and stearoyl-CoA Δ9-desaturase (Scd) is an enzyme that catalyzes the synthesis of oleic acid by desaturation of stearic acid. Plasmodium parasites can modify de novo synthesized or scavenged fatty acids into long unsaturated fatty acids. An endoplasmic reticulum (ER)-localized stearoyl-CoA desaturase (Scd) was identified in P. falciparum that catalyzes the formation of oleic acid from stearic acid by the insertion of a cis double bond at the Δ9 position of fatty acyl-CoAs.

Phenotype
Scd KO sporozoites infect the liver but fail to establish blood-stage infections in mice.
Scd KO sporozoites were allowed to invade HepG2 cells and sporozoites present inside and outside of the cells were counted, which revealed normal invasion by KO sporozoites. To analyze EEF development progress in vivo, infected mouse livers were harvested at 36, 55, and 72 hpi, and parasite burden was quantified by measuring 18S rRNA copy number using real-time PCR. We found that the 18S rRNA copy number was comparable in WT GFP and KO parasites at 36 hpi, but it was significantly lower at 55 hpi in KO parasites than in WT GFP parasites. However, the 18S rRNA copy number at 72 hpi was significantly lower in WT GFP than in KO, which suggested that mature WT GFP parasites egress from the liver but that KO parasites failed to mature and remained in the liver. We confirmed the maturation defect by determining the merozoite surface protein 1 (MSP1) transcripts at 55 hpi and found that it was significantly decreased in the KO parasites.

Scd KO liver stages grow normally but do not form hepatic merozoites.
HepG2 cells were infected with sporozoites, and the culture was fixed at different time points and stained with anti-UIS4 antibody and Hoechst. The Scd KO parasites grew similarly to the WT GFP parasites during liver-stage development. We counted the EEF numbers and measured the size at 36, 48, and 62 hpi and found comparable numbers and sizes in Scd KO and WT GFP parasites. Next, we checked the formation of merozoites by staining with an anti-MSP1 antibody. WT GFP showed nuclear segregation and merozoite formation. In contrast, there was abnormal DNA segregation in Scd KO parasites and merozoite formation was abolished. We counted the nuclei in the EEF, which were found to be significantly fewer in Scd KO parasites.

Additional information
Analysis of a mutant expressing a C-terminal 3xHA tagged version of Scd (RMgm-5551) showed the following: Scd was expressed in the blood stage and post 48 h in the liver stage. P. berghei Scd primarily colocalized to the ER in asexual blood stages and partially during liver stages.

To evaluate organelle morphology in Scd KO parasites, EEFs fixed at 62 hpi were immunostained with anti-ACP or anti-Bip antibodies to visualize apicoplast and endoplasmic reticulum branching, respectively. We found normal branching of the apicoplast and endoplasmic reticulum in WT GFP parasites, whereas it was impaired in Scd KO parasites

Other mutants


  Disrupted: Mutant parasite with a disrupted gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1110700
Gene Model P. falciparum ortholog PF3D7_0511200
Gene productStearoyl-CoA desaturase
Gene product: Alternative nameScd
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct used(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Partial or complete disruption of the geneComplete
Additional remarks partial/complete disruption
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe Scd (PbANKA_1110700) targeting vector was constructed by cloning two PCR products, F3 (578 bp) and F4 (573 bp), into the pBC-GFP-hDHFR:yFCU plasmid at XhoI/SalI and NotI/AscI, respectively. Fragments F3 and F4 were amplified from P. berghei ANKA genomic DNA. The final vector was digested with XhoI/AscI and transfected
into P. berghei schizonts.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Transgene: Mutant parasite expressing a transgene
Type and details of transgene
Is the transgene Plasmodium derived Transgene: not Plasmodium
Transgene nameGFP
Details of the genetic modification
Inducable system usedNo
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitehdhfr/yfcu
Promoter of the selectable markereef1a
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationThe Scd (PbANKA_1110700) targeting vector was constructed by cloning two PCR products, F3 (578 bp) and F4 (573 bp), into the pBC-GFP-hDHFR:yFCU plasmid at XhoI/SalI and NotI/AscI, respectively. Fragments F3 and F4 were amplified from P. berghei ANKA genomic DNA. The final vector was digested with XhoI/AscI and transfected
into P. berghei schizonts.
Additional remarks selection procedure
Other details transgene
Promoter
Gene Model of Parasite Not available
Gene Model P. falciparum ortholog Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification of the promoter sequence  Click to view information
Primer information details of the primers used for amplification of the promoter sequence  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
3'-UTR
Gene Model of Parasite Not available
Gene productNot available
Gene product: Alternative name
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to view information
Primer information details of the primers used for amplification the 3'-UTR sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Insertion/Replacement locus
Replacement / InsertionInsertion locus
Gene Model of Parasite PBANKA_1110700
Gene productStearoyl-CoA desaturase
Gene product: Alternative nameScd
Primer information details of the primers used for amplification of the target sequences  Click to view information
Primer information details of the primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4